The research protocol does not expose the participants to any risks as the study does not affect their clinical treatment. The collection of additional blood samples and adipose tissue samples during CS are the only additional study-specific procedures. These additional blood samples will be taken by a clinical member of the research team trained in phlebotomy. There is a consent request for these study-specific procedures to minimise the changes to routine clinical care and reduce the burden to participants. The risks associated with this research are minimal to participants.

All participants will be contacted at 30–40 days following CS to ask about post-surgical infections; this will not affect their clinical care in any way and does not pose any risks to participants.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.